Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-20 Purchase |
2024-08-22 5:51 pm |
Quince Therapeutics Inc. | QNCX | Ryan Charles S. PRESIDENT |
48,387 | $0.65 | $31,452 | 122,461 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-28 Option Award |
2025-02-11 5:43 pm |
N/A 2035-01-27 |
Quince Therapeutics Inc. | QNCX | Ryan Charles S. PRESIDENT |
300,000 | $0 | 300,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 6:02 pm |
N/A 2034-01-31 |
Quince Therapeutics Inc. | QNCX | Ryan Charles S. PRESIDENT |
145,000 | $0 | 145,000 (Direct) |
View |
| 2023-09-01 Option Award |
2023-09-06 5:43 pm |
N/A 2033-08-31 |
Quince Therapeutics Inc. | QNCX | Ryan Charles S. President |
545,000 | $0 | 545,000 (Direct) |
View |
Ownership |
2023-09-06 5:40 pm |
N/A N/A |
Quince Therapeutics Inc. | QNCX | Ryan Charles S. President |
0 | $0 | 74,074 (Direct) |
View |
| 2020-11-24 Option Award |
2020-11-27 5:09 pm |
N/A 2030-11-24 |
Neurotrope Inc. | NTRP | Ryan Charles S. Director 10% Owner |
40,000 | $0 | 40,000 (Direct) |
View |